Susquehanna International Group, LLP Viatris Inc Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$10.32 - $12.13 $1.52 Million - $1.79 Million	147,300 Added 20.88%	852,700 $9.9 Million
Q2 2024 Aug 15, 2024	BUY	$10.05 - $12.02 $53,265 - $63,706	5,300 Added 0.76%	705,400 $7.5 Million
Q1 2024 May 07, 2024	SELL	$11.27 - $13.53 $2.21 Million - $2.65 Million	-195,900 Reduced 21.86%	700,100 $8.36 Million
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $1.54 Million - $1.9 Million	-175,100 Reduced 16.35%	896,000 $9.7 Million
Q3 2023 Nov 14, 2023	SELL	$9.59 - $11.35 $1.76 Million - $2.09 Million	-184,000 Reduced 14.66%	1,071,100 $10.6 Million
Q2 2023 Aug 11, 2023	BUY	$9.02 - $10.29 $3.3 Million - $3.76 Million	365,500 Added 41.09%	1,255,100 $12.5 Million
Q1 2023 May 16, 2023	SELL	$9.2 - $12.26 $2.12 Million - $2.83 Million	-230,600 Reduced 20.59%	889,600 $8.56 Million
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $10.1 Million - $13.4 Million	-1,159,100 Reduced 50.85%	1,120,200 $12.5 Million
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $4.28 Million - $5.61 Million	-504,300 Reduced 18.12%	2,279,300 $19.4 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.